Kymera Therapeutics, Inc. (KYMR)
73.00
-4.81
(-6.18%)
USD |
NASDAQ |
Jan 02, 12:22
Kymera Therapeutics Total Liabilities (Quarterly): 155.79M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 37.08B |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
| Cytokinetics, Inc. | 1.958B |
| TG Therapeutics, Inc. | 417.81M |
| Protagonist Therapeutics, Inc. | 56.25M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.102B |
| Shareholders Equity (Quarterly) | 946.26M |
| Debt to Equity Ratio | 0.0888 |
| Current Ratio | 7.381 |
| Net Debt Paydown Yield | 0.02% |